Alternative donor SCT for the treatment of MHC class II deficiency.

about

Disseminated Bacillus Calmette-Guérin (BCG) infection following allogeneic hematopoietic stem cell transplant in a patient with Bare Lymphocyte Syndrome type II.Periodontal and other oral manifestations of immunodeficiency diseases.

P2860

Q36926207-FB394987-BC4C-41D5-ADDA-279A16C2AB1F Q38954801-7DD65DB5-9FB9-4DC6-A19B-007C7D69D9EB

P2860

Alternative donor SCT for the treatment of MHC class II deficiency.

Item

http://www.wikidata.org/entity/Q45698973

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Alternative donor SCT for the treatment of MHC class II deficiency.

@en

Alternative donor SCT for the treatment of MHC class II deficiency.

@nl

type

Item

label

Alternative donor SCT for the treatment of MHC class II deficiency.

@en

Alternative donor SCT for the treatment of MHC class II deficiency.

@nl

prefLabel

Alternative donor SCT for the treatment of MHC class II deficiency.

@en

Alternative donor SCT for the treatment of MHC class II deficiency.

@nl

P1476

Alternative donor SCT for the treatment of MHC class II deficiency

@en

P2093

A Scurlock

http://www.w3.org/2001/XMLSchema#string

J J Bleesing

http://www.w3.org/2001/XMLSchema#string

M Sparber-Sauer

http://www.w3.org/2001/XMLSchema#string

P Veys

http://www.w3.org/2001/XMLSchema#string

R Chiesa

http://www.w3.org/2001/XMLSchema#string

T N Small

http://www.w3.org/2001/XMLSchema#string

W Friedrich

http://www.w3.org/2001/XMLSchema#string

P2860

The bare lymphocyte syndrome and the regulation of MHC expression

MHC class II deficiency: a disease of gene regulation.

Clinical course of patients with major histocompatibility complex class II deficiency.

Nonmyeloablative, HLA-haploidentical bone marrow transplantation with high dose, post-transplantation cyclophosphamide

Omission of in vivo T-cell depletion promotes rapid expansion of naïve CD4+ cord blood lymphocytes and restores adaptive immunity within 2 months after unrelated cord blood transplant.

Major histocompatibility complex class II expression deficiency caused by a RFXANK founder mutation: a survey of 35 patients.

Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study.

Immune responses in MHC class II-deficient mice.

Major histocompatibility complex class II deficiency: a clinical review.

Allogeneic stem cell transplantation using myeloablative and reduced-intensity conditioning in patients with major histocompatibility complex class II deficiency.

P2888

bmt.2012.140

P304

226-232

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BMT.2012.140

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Waseem Qasim

P577

2012-09-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260202393

http://www.w3.org/2001/XMLSchema#string

P6179

1021501372

http://www.w3.org/2001/XMLSchema#string

P698

23000650

http://www.w3.org/2001/XMLSchema#string

Alternative donor SCT for the treatment of MHC class II deficiency.

about

P2860

P2860

Alternative donor SCT for the treatment of MHC class II deficiency.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P6179

P698